We hypothesized that increased local androgen (as could occur in patients treated with aromatase inhibitors that inhibit conversion of local androgen to estrogen), could enhance APRIL production, ultimately increasing cancer pluripotency. This evidence concerns the gene CYP19A1 and cancer.